VIPLAV PRASHANT; MEERA K S. SERUM FERRITIN LEVEL AND MYELOPEROXIDASE ACTIVITY IN TYPE 2 DIABETIC MALES ON ORAL HYPOGLYCEMIC AGENTS. International Journal of Pharma and Bio Sciences, [S. l.], v. 5, n. 4, p. 373–386, 2014. Disponível em: https://ijpbs.net/index.php/journal/article/view/3672. Acesso em: 24 jul. 2026.